Oncotarget

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. The journal was established in 20101 and is published by Impact Journals. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov.

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. The journal was established in 2010 and is published by Impact Journals. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov.

Abstracting and indexing

The journal is abstracted and indexed in Index Medicus/MEDLINE/PubMed and Scopus. In 2022, it was re-indexed by Index Medicus/MEDLINE after being dropped in 2017. In 2018 Clarivate delisted the journal from the Journal Citation Reports and all of its other products because "the journal no longer meets the standards necessary for continued coverage", despite having listed the journal as a "Rising Star from Essential Science Indicators" only a few months prior.

Reception

The peer review process employed by the journal has been criticized by Jeffrey Beall, a university librarian and expert on predatory open access publishing, who also included the journal on his list of "potential, possible, or probable predatory scholarly open-access journals" in July 2015. Allegedly, journal editor Mikhail Blagosklonny responded by threatening to retract the papers of Beall's colleagues at the University of Colorado.

References

External links

Text derived from https://en.wikipedia.org/w/index.php?oldid=1373068801 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “Oncotarget” revision 1373068801 · retrieved 2026-10-20 date of establishment (×1) · confidence 0.95 revision URL